Vaso Corp Share Price Other OTC
Equities
US9223211049
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
01/04 | Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01/04 | Vaso Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2022 | 8Cr 667.83Cr | Sales 2023 | 8.1Cr 676.23Cr | Capitalization | 5.35Cr 446.29Cr |
---|---|---|---|---|---|
Net income 2022 | 1.1Cr 92Cr | Net income 2023 | 40L 33Cr | EV / Sales 2022 | 0.13 x |
Net cash position 2022 | 1.85Cr 154.53Cr | Net cash position 2023 | 2.33Cr 194.14Cr | EV / Sales 2023 | 0.37 x |
P/E ratio 2022 |
2.41
x | P/E ratio 2023 |
11.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 52.4% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Ma
CEO | Chief Executive Officer | 60 | 01/07/01 |
Jonathan Newton
DFI | Director of Finance/CFO | 63 | 01/10/01 |
Michael Beecher
DFI | Director of Finance/CFO | 79 | 21/11/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Castle
COO | Chief Operating Officer | 55 | 19/10/19 |
Jun Ma
CEO | Chief Executive Officer | 60 | 01/07/01 |
David Lieberman
BRD | Director/Board Member | 79 | 28/11/28 |
1st Jan change | Capi. | |
---|---|---|
+12.85% | 23TCr | |
+13.88% | 20TCr | |
+18.39% | 14TCr | |
+28.78% | 11TCr | |
+2.43% | 6.49TCr | |
+18.24% | 5.43TCr | |
+7.04% | 5.21TCr | |
+10.83% | 4.52TCr | |
+5.94% | 3.74TCr |